| Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies KBE Moore, TJ Hung, JS Fortin Drug discovery today 28 (3), 103487, 2023 | 20 | 2023 |
| Revisiting misfolding propensity of serum amyloid A1: special focus on the signal peptide region MS Haines, E Ramirez, KBE Moore, JS Fortin Biochemistry and Biophysics Reports 31, 101284, 2022 | 6 | 2022 |
| Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment AA Smith, KBE Moore, PM Ambs, AP Saraswati, JS Fortin Advanced Biology 6 (10), 2101301, 2022 | 2 | 2022 |
| Revisiting Small Molecule Inhibitors of Amyloid‐β Aggregation KBE Moore, JPT Pirela, JS Fortin The FASEB Journal 36, 2022 | 2 | 2022 |
| Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region NG Horgan, KBE Moore, JS Fortin Veterinary Quarterly 43 (1), 1-8, 2023 | | 2023 |
| Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules KBE Moore, NG Horgan, B Lenters, JS Fortin Veterinary Quarterly 43 (1), 1-12, 2023 | | 2023 |
| 2-(4-aminophenyl) benzothiazole Derivatives Modulate Transthyretin Aggregation V Grandhe, K BE, AP Saraswati, JS Fortin AMERICAN JOURNAL OF PATHOLOGY 192 (9), S10-S10, 2022 | | 2022 |
Jessica S FortinAssistant Professor, Purdue University在 purdue.edu 的电子邮件经过验证
Jessica S FortinAssistant Professor, Purdue University在 purdue.edu 的电子邮件经过验证